Titterton Lewis H jr: insider trades.
Titterton Lewis H jr reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 4 open-market purchases ($210K) and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 4
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Titterton Lewis H jr
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Anixa Biosciences Inc (ANIX) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Anixa Biosciences Inc | P | 49,036 | $2.69 | 1,046,003 | Form 4 |
| 2026-09-10 | Anixa Biosciences Inc | P | 10,000 | $2.73 | 996,967 | Form 4 |
| 2026-07-20 | Anixa Biosciences Inc | P | 12,000 | $3.47 | 986,967 | Form 4 |
| 2026-07-15 | Anixa Biosciences Inc | P | 2,797 | $3.28 | 974,967 | Form 4 |
Questions
What stock did Titterton Lewis H jr buy or sell?
Titterton Lewis H jr reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 4 open-market purchases ($210K) and 0 sales, across 1 company.
Is Titterton Lewis H jr the same person as other filers with this name?
This page covers SEC CIK 1499254 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/titterton-lewis-h-jr-1499254.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.